Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NUC-7738 in Advanced Solid Tumours and Lymphoma
NCT03829254Phase 2Recruiting
- Sponsor
- NuCana
- Start
- Jun 2019
- Primary completion
- Aug 2026
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of NUC-7738 in solid tumor (advanced stage), lymphoma, melanoma, sponsored by NuCana. Started Jun 2019; status: recruiting.
02
Drugs
NUC-7738
03
Conditions
solid tumor (advanced stage)lymphomamelanoma
Beyond the preview
Go deeper on NCT03829254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03829254.